Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06336538 · ClinicalTrials.gov registry record · NA
Abbreviated MBCT for Depression in Older African American/Black Breast Cancer Survivors
A NA study of Breast Cancer and Breast Cancer Female, sponsored by Case Comprehensive Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT06336538: Active NA study of Breast Cancer and Breast Cancer Female, sponsored by Case Comprehensive Cancer Center.
NCT06336538 is a NA study of Breast Cancer and Breast Cancer Female that is active but no longer recruiting, run by Case Comprehensive Cancer Center. The registered enrollment target is 23 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06336538, a NA study of Breast Cancer and Breast Cancer Female, is active but no longer recruiting, sponsored by Case Comprehensive Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to develop and test an intervention designed to improve mood and reduce symptoms of depression.
Primary Outcome
Feasibility rate is measured by calculating the mean percent of intervention sessions attended by the participants
Conditions Studied
Interventions
- OTHER MBCT
Study Locations (1)
Ohio
- Cleveland Clinic Department of Wellness and Preventive Medicine - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2025-03-21 |
| Est. Completion | 2026-09 |
| Phase | NA |
What the registry record for NCT06336538 still lists
NCT06336538 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower).
The record links to 7 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which MBCT is the first listed.
NCT06336538 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06336538 about?
NCT06336538 is a clinical study titled "Abbreviated MBCT for Depression in Older African American/Black Breast Cancer Survivors". The purpose of this research study is to develop and test an intervention designed to improve mood and reduce symptoms of depression.
What is the current status of trial NCT06336538?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 23 participants. The study started on 2025-03-21. Estimated completion is 2026-09.
What conditions does trial NCT06336538 study?
This clinical trial studies the following conditions: Breast Cancer, Breast Cancer Female, Breast Cancer Stage II, Breast Cancer Stage III, Breast Cancer Stage I.
What interventions are being tested in trial NCT06336538?
The interventions under investigation include: MBCT (OTHER).
Who is sponsoring clinical trial NCT06336538?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06336538 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06336538's enrollment target sits among peer trials
23 1056th of 1224 higher than 163 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI